Lanny Kirsch MD

Lanny after receiving his MD from Harvard University Medical School, Dr Lanny Kirsch completed his residency at Children’s Hospital Medical Center in Boston, a fellowship in Pediatric Hematology/Oncology at the National Cancer Institute (NCI), and a postdoctoral fellowship in molecular genetics at the National Institute of Child Health and Human Development. Subsequently, Dr Kirsch spent over 20 years at the NCI as a basic researcher, attending physician, and, ultimately, Chief of the Genetics Branch within the Center for Cancer Research.

Dr Kirsch’s research has focused on cancer-specific genetic instability and cancer genetics. In 2005 Dr Kirsch joined the biotech/pharma company Amgen as an Executive Director heading the Oncology Research group at Amgen Washington in Seattle. During the next six years, the Amgen Washington group brought several different therapeutic targets and modalities to Phase 1 trial evaluation and provided basic research support for many marketed projects or projects in late-stage clinical development. Dr Kirsch has also been an independent consultant to the biotech/pharma industry, with extended assignments focused on the development of antibody therapeutics and molecular diagnostics.